C30H26O13
Neat
594.53
Room Temperature
Tiliroside; 20316-62-5; Trans-Tiliroside; 15M04TXR9M; DTXSID601021936; RONACARE TILIROSIDE; [(2R, 3S, 4S, 5R, 6S)-6-[5, 7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3, 4, 5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate; ((2R, 3S, 4S, 5R, 6S)-6-(5, 7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl)oxy-3, 4, 5-trihydroxyoxan-2-yl)methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate; RefChem:898122; DTXCID201506849; ((2R, 3S, 6S)-6-(5, 7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl)oxy-3, 4, 5-trihydroxyoxan-2-yl)methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate; Tribuloside; 22153-44-2; Potengriffioside A; MFCD00017454; CHEMBL266564; ((2R, 3S, 4S, 5R, 6S)-6-((5, 7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3, 4, 5-trihydroxytetrahydro-2H-pyran-2-yl)methyl 3-(4-hydroxyphenyl)acrylate; 2-Propenoic acid, 3-(4-hydroxyphenyl)-, 6'-ester with 3-(beta-D-glucopyranosyloxy)-5, 7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; ((2R, 3S, 4S, 5R, 6S)-6-((5, 7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy)-3, 4, 5-trihydroxytetrahydro-2H-pyran-2-yl)methyl (E)-3-(4-hydroxyphenyl)acrylate; [(2R, 3S, 4S, 5R, 6S)-6-[5, 7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-3-yl]oxy-3, 4 and 5-trihydroxy-tetrahydropyran-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate
[(2R, 3S, 4S, 5R, 6S)-6-[5, 7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3, 4 and 5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate
InChI=1S/C30H26O13/c31-16-6-1-14(2-7-16)3-10-22(35)40-13-21-24(36)26(38)27(39)30(42-21)43-29-25(37)23-19(34)11-18(33)12-20(23)41-28(29)15-4-8-17(32)9-5-15/h1-12,21,24,26-27,30-34,36,38-39H,13H2/b10-3+/t21-,24-,26+,27-,30+/m1/s1